RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cassava Sciences - Stock

Cassava Sciences P/S 2024

Cassava Sciences P/S

0

Ticker

SAVA

ISIN

US14817C1071

WKN

A2PGL8

As of Jul 7, 2024, Cassava Sciences's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Cassava Sciences P/S history

Cassava Sciences Aktienanalyse

What does Cassava Sciences do?

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Cassava Sciences's P/S Ratio

Cassava Sciences's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Cassava Sciences's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Cassava Sciences's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Cassava Sciences’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Cassava Sciences stock

What is the price-to-earnings ratio of Cassava Sciences?

The price-earnings ratio of Cassava Sciences is currently 0.

How has the price-earnings ratio of Cassava Sciences changed compared to last year?

The price-to-earnings ratio of Cassava Sciences has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Cassava Sciences high compared to other companies?

Yes, the price-to-earnings ratio of Cassava Sciences is high compared to other companies.

How does an increase in the price-earnings ratio of Cassava Sciences affect the company?

An increase in the price-earnings ratio of Cassava Sciences would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Cassava Sciences affect the company?

A decrease in the price-earnings ratio of Cassava Sciences would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Cassava Sciences?

Some factors that influence the price-earnings ratio of Cassava Sciences are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Cassava Sciences pay?

Over the past 12 months, Cassava Sciences paid a dividend of 5.25 USD . This corresponds to a dividend yield of about 51.4 %. For the coming 12 months, Cassava Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cassava Sciences?

The current dividend yield of Cassava Sciences is 51.4 %.

When does Cassava Sciences pay dividends?

Cassava Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cassava Sciences?

Cassava Sciences paid dividends every year for the past 0 years.

What is the dividend of Cassava Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cassava Sciences located?

Cassava Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cassava Sciences from 12/24/2012 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 12/13/2012.

When did Cassava Sciences pay the last dividend?

The last dividend was paid out on 12/24/2012.

What was the dividend of Cassava Sciences in the year 2023?

In the year 2023, Cassava Sciences distributed 0 USD as dividends.

In which currency does Cassava Sciences pay out the dividend?

The dividends of Cassava Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cassava Sciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cassava Sciences

Our stock analysis for Cassava Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cassava Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.